Literature DB >> 27274175

Risk Factors for Thrombosis, Overshunting and Death in Infants after Modified Blalock-Taussig Shunt.

Mehmet Küçük1, Rahmi Özdemir1, Mustafa Karaçelik2, Önder Doksöz1, Cem Karadeniz1, Yılmaz Yozgat1, Timur Meşe1, Nejat Sarıosmanoğlu2.   

Abstract

BACKGROUND: The Modified Blalock-Taussig shunt procedure can provide increased flow of blood to the lungs for babies born with certain congenital heart defects. We evaluated 44 subjects under 2 years of age who had a Modified Blalock-Taussig shunt (MBTS) procedure performed from 2009-2013, to investigate risk factors for thrombosis, overshunting and death.
METHODS: The study subjects included in our investigation were severely cyanotic newborns with pulmonary stenosis or atresia and duct dependent circulation, and infants having Tetralogy of Fallot with small pulmonary arteries who underwent a MBTS procedure in our facility from 2009-2013. We duly noted patient preoperative characteristics such as hemoglobin, hematocrit, mean platelet volume, prothrombin time and partial thromboplastin time. Our study investigated the risk factors for post-operative overcirculation, thrombosis and death.
RESULTS: The age and weight of patients in our study at the time of procedure ranged from 1 day to 20 months old (median 12 days), and 2.4 kg to 12 kg (mean 4.6 kg), respectively. A total of 8 patients died following surgery, and. 4 (9.1%) had shunt thrombosis, of which one died during shunt revision. Partial thromboplastin time was 28.7 seconds in patients with thrombosis, and 35 in all other patients (p = 0.04). Overcirculation was detected in 5 patients; shunt size/body weight was 1.25 in patients who had overcirculation, and 1.06 in all other patients.
CONCLUSIONS: It is important to assess risk factors associated with the MBTS operation. The results of our study suggest that a preoperative low aPTT value may be an indicator for thrombosis in infants who have undergone MBTS surgery.

Entities:  

Keywords:  Activated partial thromboplastin time; Risk factors; Shunt thrombosis

Year:  2016        PMID: 27274175      PMCID: PMC4884762          DOI: 10.6515/acs20150731a

Source DB:  PubMed          Journal:  Acta Cardiol Sin        ISSN: 1011-6842            Impact factor:   2.672


  16 in total

1.  Mean platelet volume: a quick, easy determinant of thrombotic risk?

Authors:  S J Machin; C Briggs
Journal:  J Thromb Haemost       Date:  2009-10-30       Impact factor: 5.824

2.  Modified Blalock Taussig shunt: a not-so-simple palliative procedure.

Authors:  Verena Dirks; René Prêtre; Walter Knirsch; Emanuela R Valsangiacomo Buechel; Burkhardt Seifert; Martin Schweiger; Michael Hübler; Hitendu Dave
Journal:  Eur J Cardiothorac Surg       Date:  2013-03-28       Impact factor: 4.191

3.  Modified Blalock-Taussig shunts: results in infants less than 3 months of age.

Authors:  D Tamisier; P R Vouhé; F Vernant; F Lecá; C Massot; J Y Neveux
Journal:  Ann Thorac Surg       Date:  1990-05       Impact factor: 4.330

4.  Modified Blalock-Taussig shunt: statistical analysis of potential factors influencing shunt outcome.

Authors:  K T Tsai; C H Chang; P J Lin
Journal:  J Cardiovasc Surg (Torino)       Date:  1996-04       Impact factor: 1.888

5.  Blalock-Taussig shunt: experience from the developing world.

Authors:  Jamal S Rana; Kaashif A Ahmad; Aliya S Shamim; Sulaiman B Hassan; Mehnaz A Ahmed
Journal:  Heart Lung Circ       Date:  2002       Impact factor: 2.975

6.  In-hospital shunt occlusion in infants undergoing a modified blalock-taussig shunt.

Authors:  Nina A Guzzetta; Gregory S Foster; Navyata Mruthinti; Patrick D Kilgore; Bruce E Miller; Kirk R Kanter
Journal:  Ann Thorac Surg       Date:  2013-05-11       Impact factor: 4.330

7.  Two thousand Blalock-Taussig shunts: a six-decade experience.

Authors:  Jason A Williams; Anshuman K Bansal; Bradford J Kim; Lois U Nwakanma; Nishant D Patel; Akhil K Seth; Diane E Alejo; Vincent L Gott; Luca A Vricella; William A Baumgartner; Duke E Cameron
Journal:  Ann Thorac Surg       Date:  2007-12       Impact factor: 4.330

8.  Experience with the modified Blalock-Taussig operation using polytetrafluoroethylene (Impra) grafts.

Authors:  P H Kay; A Capuani; R Franks; C Lincoln
Journal:  Br Heart J       Date:  1983-04

9.  Modified Blalock-Taussig shunt: immediate and short-term follow-up results in neonates.

Authors:  Usman Ahmad; Saulat H Fatimi; Iqil Naqvi; Mehnaz Atiq; Sonia S Moizuddin; Khuda Bux Sheikh; Syed Shahbuddin; Tariq M Naseem; Muhammad A Javed
Journal:  Heart Lung Circ       Date:  2007-08-01       Impact factor: 2.975

10.  Modified Blalock-Taussig shunt in infants and young children. Clinical and catheterization assessment.

Authors:  P P Karpawich; C P Bush; J R Antillon; J J Amato; M L Marbey; K C Agarwal
Journal:  J Thorac Cardiovasc Surg       Date:  1985-02       Impact factor: 5.209

View more
  7 in total

Review 1.  A Narrative Review of Postoperative Anticoagulation Therapy for Congenital Cardiac Disease.

Authors:  Alexander A Boucher; Julia A Heneghan; Subin Jang; Kaitlyn A Spillane; Aaron M Abarbanell; Marie E Steiner; Andrew D Meyer
Journal:  Front Surg       Date:  2022-06-14

2.  The Prediction Model of Warfarin Individual Maintenance Dose for Patients Undergoing Heart Valve Replacement, Based on the Back Propagation Neural Network.

Authors:  Qian Li; Jing Wang; Huan Tao; Qin Zhou; Jie Chen; Bo Fu; WenZhe Qin; Dong Li; JiangLong Hou; Jin Chen; Wei-Hong Zhang
Journal:  Clin Drug Investig       Date:  2020-01       Impact factor: 2.859

3.  The Effects of the Mechanical Properties of Vascular Grafts and an Anisotropic Hyperelastic Aortic Model on Local Hemodynamics during Modified Blalock-Taussig Shunt Operation, Assessed Using FSI Simulation.

Authors:  Alex G Kuchumov; Aleksandr Khairulin; Marina Shmurak; Artem Porodikov; Andrey Merzlyakov
Journal:  Materials (Basel)       Date:  2022-04-07       Impact factor: 3.748

4.  Warfarin maintenance dose Prediction for Patients undergoing heart valve replacement- a hybrid model with genetic algorithm and Back-Propagation neural network.

Authors:  Qian Li; Huan Tao; Jing Wang; Qin Zhou; Jie Chen; Wen Zhe Qin; Li Dong; Bo Fu; Jiang Long Hou; Jin Chen; Wei-Hong Zhang
Journal:  Sci Rep       Date:  2018-06-26       Impact factor: 4.379

5.  Predictors of death after receiving a modified Blalock-Taussig shunt in cyanotic heart children: A competing risk analysis.

Authors:  Maliwan Oofuvong; Jutarat Tanasansuttiporn; Wirat Wasinwong; Voravit Chittithavorn; Pongsanae Duangpakdee; Jirayut Jarutach; Qistina Yunuswangsa
Journal:  PLoS One       Date:  2021-01-22       Impact factor: 3.240

6.  Cardiac Catheterization in the Early Post-Operative Period after Congenital Heart Surgery.

Authors:  Taner Kasar; Ibrahim Cansaran Tanidir; Erkut Ozturk; Candas Kafali; Murat Sahin; Okan Yildiz; Sertac Haydin; Alper Guzeltas
Journal:  Acta Cardiol Sin       Date:  2018-11       Impact factor: 2.672

7.  Effects of protocol-based management on the post-operative outcome after systemic to pulmonary shunt.

Authors:  Sameh R Ismail; Muneira M Almazmi; Rajab Khokhar; Wedad AlMadani; Ali Hadadi; Omar Hijazi; Mohamed S Kabbani; Ghassan Shaath; Mahmoud Elbarbary
Journal:  Egypt Heart J       Date:  2018-10-28
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.